Kaplan-Meier curves demonstrated a trend toward CGM new users achieving a ≥1% reduction in HbA1c sooner than never users, although this difference did not reach statistical significance (log-rank P = .095).
← all excerpts
Impact of Medicaid Continuous Glucose Monitor Expansion on Uptake, Glycemic Outcomes, and Engagement Among Adults With Type 2 Diabetes in a Federally Qualified Health Center.
1
0.0950
0.0950